| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $1.99 In Line |
| EPS GAAP Actual | $1.99 In Line |
| Revenue Actual | $1.7709B |
| Revenue Surprise | Beat by $1770.9M |
| Announce Date | 12/27/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.33828 |
| EPS GAAP Estimate | $2.33828 |
| Revenue Estimate | $2.0254B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 9.46068 | 21.3 | 9.06437 | 9.85699 | 2 |
| Dec 2027 | 9.48 | 21.25 | 9.12808 | 10.00277 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.09 | 0.59346 | 1.7709B | 10.44% | -2305.98M |
| FQ2 2025 (Jun 2025) | 2.08 | 2.08 | 1.81456B | 16.97% | 1814.56M |
| FQ1 2025 (Mar 2025) | 1.73 | 1.73 | 1.5351B | 10% | 1535.1M |
| FQ4 2024 (Dec 2024) | 2.27 | 2.27 | 1.82256B | 18.66% | 1822.56M |
| FQ3 2024 (Sep 2024) | 2.08 | 2.08 | 1.58602B | 16.72% | 1586.02M |
| FQ2 2024 (Jun 2024) | 1.57 | 1.57 | 1.50667B | 100% | 1506.67M |
| FQ1 2024 (Mar 2024) | 1.44 | 1.44 | 1.38165B | 100% | 1381.65M |
| FQ4 2023 (Dec 2023) | 2.83 | 2.83 | 1.4825B | 11.88% | 1482.5M |
FQ4 Announce Date
12/27/2025 (Pre-Market)
Consensus EPS Estimates
2.33828
Consensus Revenue Estimates
2.0254B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 2.59742 | -- | 2.54895 | 2.65811 | 2 |
| FQ3 2026 (Sep 2026) | 2.145 | 2.56 | 2.0732 | 2.23653 | 2 |
| FQ2 2026 (Jun 2026) | 2.08 | 0 | 2.01038 | 2.16876 | 2 |
| FQ1 2026 (Mar 2026) | 1.745 | 0.86 | 1.68659 | 1.81947 | 2 |
| FQ4 2025 (Dec 2025) | 2.33828 | 2.92 | 2.30765 | 2.39954 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 2.21B | -- | 2.18B | 2.25B | 3 |
| FQ3 2026 (Sep 2026) | 2.19B | 19.24 | 2.14B | 2.26B | 1 |
| FQ2 2026 (Jun 2026) | 2.14B | 15.03 | 2.08B | 2.21B | 1 |
| FQ1 2026 (Mar 2026) | 2.08B | 26.19 | 2.03B | 2.15B | 1 |
| FQ4 2025 (Dec 2025) | 2.03B | 10.01 | 2.01B | 2.05B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.49654 | 2.09 | 0.59346 | 28.4% |
| FQ2 2025 (Jun 2025) | 2.08 | 2.08 | 100% | |
| FQ1 2025 (Mar 2025) | 1.73 | 1.73 | 100% | |
| FQ4 2024 (Dec 2024) | 2.27 | 2.27 | 100% | |
| FQ3 2024 (Sep 2024) | 2.08 | 2.08 | 100% | |
| FQ2 2024 (Jun 2024) | 1.57 | 1.57 | 100% | |
| FQ1 2024 (Mar 2024) | 1.44 | 1.44 | 100% | |
| FQ4 2023 (Dec 2023) | 2.83 | 2.83 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $4.08B | $1.77B | $-2305.98M | -130.22% |
| FQ2 2025 (Jun 2025) | $0B | $1.81B | $1814.56M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.54B | $1535.1M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.82B | $1822.56M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.59B | $1586.02M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.51B | $1506.67M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.38B | $1381.65M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.48B | $1482.5M | 100% |